Research
Periodic Report
Gland Pharma, Tejas Networks, and Mankind Pharma Suffer Losses Ahead of Earnings and Corporate Changes .
Gland Pharma, Tejas Networks, and Mankind Pharma Suffer Losses Ahead of Earnings and Corporate Changes .
Written by - Fisdom Research
Array
January 24, 2025
2 minutes
Array
Market Snapshot
Market sentiment remains weak, leading to selloffs even when earnings meet expectations.
The broader market is under pressure, but large-cap stocks are showing resilience.
The Indian market has historically navigated multiple challenges, from the taper tantrum to geopolitical risks.
Q3FY25 earnings have largely aligned with muted expectations, but lackluster management commentary is adding to negative sentiment.
Foreign Portfolio Investor (FPI) flows are expected to remain volatile in the near term.
Sectoral Trends
Sector Name
% Change
Sector Name
% Change
NIFTY FMCG
0.5
NIFTY PRIVATE BANK
-0.5
NIFTY IT
0.4
NIFTY METAL
-0.9
NIFTY BANK
-0.5
NIFTY CONSUMER DURABLES
-1.2
NIFTY FINANCIAL SERVICES
-0.5
NIFTY PSU BANK
-1.4
Top News
Gland Pharma’s share price dropped 3.17% to Rs 1,571 after the NSE announced it would exclude the company’s shares from the F&O segment starting January 31, ahead of its earnings report on February 3.
Tejas Networks’ share price fell over 9% despite reporting a net profit of Rs 165.67 crore for Q3FY25, though it saw a 40% sequential decline and a drop in its order book.
Mankind Pharma’s shares declined nearly 6% following a 16% year-on-year drop in Q3 net profit to Rs 385 crore, partly due to the acquisition of Bharat Serums and Vaccines.
BPCL board OK’s Rs. 1000 crore Maharashtra Natural Gas IPO
Coating emulsions and adhesives maker Jesons Industries plans IPO
Technical Outlook: Key Indices
Indices Name
Support
Resistance
Nifty
23,000
23,500
Bank Nifty
48,000
50,000
Top Gainers and Losers
Top Gainers
% Change
Top Losers
% Change
HINDUNILVR
2.5
DRREDDY
-4.9
BRITANNIA
1.7
TRENT
-4.1
EICHERMOT
1.5
M&M
-3.0
Trade Ideas Update
Our trade ideas success rate has 62% over the past month, even with increased volatility in the benchmark index. Follow Trade Ideas for timely stock insights.
